ITK and RLK inhibitor improves skin disease in a psoriatic mouse model

被引：0
|
作者：
Fuhriman, J. M. [1 ]
Winge, M. C. G. [1 ]
Haberstock-Debic, H. [2 ]
Funk, J. Oliver [2 ]
Bradshaw, M. [2 ]
Marinkovich, M. [3 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Principia Biopharma Inc, San Francisco, CA USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 05期
关键词：
D O I：
10.1016/j.jid.2017.02.723
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
700
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [31] A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria
    Fong, LG
    Frost, D
    Meta, M
    Qiao, X
    Yang, SH
    Coffinier, C
    Young, SG
    SCIENCE, 2006, 311 (5767) : 1621 - 1623
  • [32] The Effect of Trichostatin A, One of the Histone Deacetylase Inhibitor, on Skin Fibrosis Mouse Model
    Ogawa, Fumihide
    Tomita, Hajime
    Kuwatsuka, Yutaka
    Shimizu, Kazuhiro
    Sato, Shinichi
    Utani, Atsushi
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S580 - S580
  • [33] The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves GvHD in mouse
    Decker, CJ
    Heiser, AD
    Faust, T
    Ku, G
    Mosely, S
    Nimmesgern, E
    TRANSPLANTATION, 1999, 67 (07) : S57 - S57
  • [34] A transgenic mouse model with an inducible skin blistering disease phenotype
    Takahashi, K
    Coulombe, PA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) : 14776 - 14781
  • [35] Psoriatic skin model: Evaluation of percutaneous absorption
    Pouliot, R.
    Duque-Fernandez, A.
    Soucy, J.
    TISSUE ENGINEERING PART A, 2008, 14 (05) : 900 - 901
  • [36] ESTABLISHMENT OF A PSORIATIC SKIN MODEL FOR A-IRRADIATION
    Wiedemann, Julia
    Grunebaum, Valeria
    Witzler, Claudius
    Dornhecker, Maximilian
    Lerchl, Sylvie
    Fournier, Claudia
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 59 - 59
  • [37] Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
    Garcia-Miralles, Marta
    Ooi, Jolene
    Bardile, Costanza Ferrari
    Tan, Liang Juin
    George, Maya
    Drum, Chester L.
    Lin, Rachel Yanping
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    EXPERIMENTAL NEUROLOGY, 2016, 278 : 4 - 10
  • [38] Oxylipin Profile Is Associated with Skin Disease and Enthesitis in Psoriatic Disease
    Coras, Roxana
    Kavanaugh, Arthur
    Kluzniak, Angela
    Holt, Dustina
    Weilgosz, Amy
    Quehenberger, Oswald
    Ritchlin, Christopher
    Guma, Monica
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] Duration of Psoriatic Skin Disease as Risk Factor for Subsequent Onset of Psoriatic Arthritis
    Egeberg, Alexander
    Skov, Lone
    Zachariae, Claus
    Gislason, Gunnar H.
    Thyssen, Jacob P.
    Mallbris, Lotus
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (06) : 546 - 550
  • [40] Treatment with a MEK Inhibitor Improves Myeloproliferation, Anemia and Survival in a Mouse Model of CMML and JMML
    Lyubyn-Ska, Natalya
    Lauchle, Jennifer
    Shannon, Kevin
    Braun, Benjamin S.
    BLOOD, 2009, 114 (22) : 399 - 399
12345